Please wait while the formulary information is being retrieved.
M-HIST PD (TRIPROLIDINE HCL)
- Allergic rhinitis
- Pruritus of skin
- Rhinorrhea
- Allergic conjunctivitis
- Anaphylaxis adjunct
- Dermatographic urticaria
- Nasal congestion
- Sneezing
- Urticaria
- Vasomotor rhinitis
- Vanahist Pd Oral Drops
- Triprolidine Hcl Oral Drops
- Pediaclear Pd Oral Drops
- M-hist Pd Oral Drops
- By Indication
0.625 mg/mL oral drops
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
0.313 mg/mL oral drops
- Dosage information is not available
0.625 mg/mL oral drops
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
0.938 mg/mL oral drops
- Dosage information is not available
1.25 mg/mL oral drops
- Dosage information is not available
0.625 mg/mL oral drops
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
0.625 mg/mL oral drops
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
Allergic conjunctivitis
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours as needed notto exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours not to exceed4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 6 hours as needed
- 4 milliliters (2.5 mg) by oral route every 6 hours
Allergic rhinitis
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours as needed notto exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours not to exceed4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 6 hours as needed
- 4 milliliters (2.5 mg) by oral route every 6 hours
Anaphylaxis adjunct
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours as needed notto exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours not to exceed4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 6 hours as needed
- 4 milliliters (2.5 mg) by oral route every 6 hours
Dermatographic urticaria
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours as needed notto exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours not to exceed4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 6 hours as needed
- 4 milliliters (2.5 mg) by oral route every 6 hours
Nasal congestion
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours as needed notto exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours not to exceed4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 6 hours as needed
- 4 milliliters (2.5 mg) by oral route every 6 hours
Pruritus of skin
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours as needed notto exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours not to exceed4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 6 hours as needed
- 4 milliliters (2.5 mg) by oral route every 6 hours
Rhinorrhea
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours as needed notto exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours not to exceed4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 6 hours as needed
- 4 milliliters (2.5 mg) by oral route every 6 hours
Sneezing
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours as needed notto exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours not to exceed4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 6 hours as needed
- 4 milliliters (2.5 mg) by oral route every 6 hours
Urticaria
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours as needed notto exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours not to exceed4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 6 hours as needed
- 4 milliliters (2.5 mg) by oral route every 6 hours
Vasomotor rhinitis
- 4 milliliters (2.5 mg) by oral route every 4-6 hours as needed not to exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours as needed notto exceed 4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 4 hours not to exceed4 doses in 24Hrs
- 4 milliliters (2.5 mg) by oral route every 6 hours as needed
- 4 milliliters (2.5 mg) by oral route every 6 hours
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Angle-closure glaucoma
- Benign prostatic hyperplasia
- Bladder outflow obstruction
- Chronic idiopathic constipation
- Stenosing peptic ulcer
- Urinary retention
Severe
Moderate
- Hypertension
- Hyperthyroidism
- Ocular hypertension
M-HIST PD (TRIPROLIDINE HCL)
- Allergic rhinitis
- Pruritus of skin
- Rhinorrhea
- Allergic conjunctivitis
- Anaphylaxis adjunct
- Dermatographic urticaria
- Nasal congestion
- Sneezing
- Urticaria
- Vasomotor rhinitis
- None
- Dizziness
- Drowsy
- Thick bronchial secretions
More Frequent
Severe
Less Severe
- None
- Sedation
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Blood dyscrasias
- Extrasystoles
- Hallucinations
- Hemolytic anemia
- Hypotension
- Seizure disorder
Less Severe
- Abdominal distension
- Acute abdominal pain
- Acute confusion
- Anorexia
- Ataxia
- Blurred vision
- Chest discomfort
- Chills
- Constipation
- Diarrhea
- Diplopia
- Dry nose
- Dry throat
- Dyspnea
- Dysuria
- Euphoria
- Excitement
- Fatigue
- Headache disorder
- Hyperhidrosis
- Insomnia
- Irritability
- Maculopapular rash
- Malaise
- Migraine
- Nervousness
- Nightmares
- Palpitations
- Paresthesia
- Pruritus of skin
- Skin photosensitivity
- Skin rash
- Symptoms of anxiety
- Tachycardia
- Tinnitus
- Tremor
- Urinary retention
- Urticaria
- Vertigo
- Visual changes
- Wheezing
- Xerostomia
Contraindicated
Triprolidine
Use not recommended age <4 months. CNS excitation and seizure risk in newborns.
Risk of CNS & respiratory depression, excitation. Do not use age < 6 yr
- 1 Day – 119 Days
- 1 Use not recommended age <4 months. CNS excitation and seizure risk in newborns.
- 1 Risk of CNS & respiratory depression, excitation. Do not use age < 6 yr
- 120 Days – 6 Years
- 1 Use not recommended age <4 months. CNS excitation and seizure risk in newborns.
- 1 Risk of CNS & respiratory depression, excitation. Do not use age < 6 yr
Severe Precaution
None
Management or Monitoring Precaution
None
Triprolidine
- Severity Level:
C
- Additional Notes: Fda category c in combination product
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Allergic conjunctivitis | |
| H10.1 | Acute atopic conjunctivitis |
| H10.10 | Acute atopic conjunctivitis, unspecified eye |
| H10.11 | Acute atopic conjunctivitis, right eye |
| H10.12 | Acute atopic conjunctivitis, left eye |
| H10.13 | Acute atopic conjunctivitis, bilateral |
| H10.44 | Vernal conjunctivitis |
| H10.45 | Other chronic allergic conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| Allergic rhinitis | |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J30.5 | Allergic rhinitis due to food |
| J30.8 | Other allergic rhinitis |
| J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
| J30.89 | Other allergic rhinitis |
| J30.9 | Allergic rhinitis, unspecified |
| Anaphylaxis adjunct | |
| T78.00xA | Anaphylactic reaction due to unspecified food, initial encounter |
| T78.01xA | Anaphylactic reaction due to peanuts, initial encounter |
| T78.02xA | Anaphylactic reaction due to shellfish (crustaceans), initial encounter |
| T78.03xA | Anaphylactic reaction due to other fish, initial encounter |
| T78.04xA | Anaphylactic reaction due to fruits and vegetables, initial encounter |
| T78.05xA | Anaphylactic reaction due to tree nuts and seeds, initial encounter |
| T78.06xA | Anaphylactic reaction due to food additives, initial encounter |
| T78.07xA | Anaphylactic reaction due to milk and dairy products, initial encounter |
| T78.08xA | Anaphylactic reaction due to eggs, initial encounter |
| T78.09xA | Anaphylactic reaction due to other food products, initial encounter |
| T78.2xxA | Anaphylactic shock, unspecified, initial encounter |
| T80.51 | Anaphylactic reaction due to administration of blood and blood products |
| T80.52xA | Anaphylactic reaction due to vaccination, initial encounter |
| T80.59xA | Anaphylactic reaction due to other serum, initial encounter |
| T88.6xxA | Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, initial encounter |
| Dermatographic urticaria | |
| L50.3 | Dermatographic urticaria |
| Nasal congestion | |
| R09.81 | Nasal congestion |
| Pruritus of skin | |
| L29.8 | Other pruritus |
| L29.9 | Pruritus, unspecified |
| Rhinorrhea | |
| R09.82 | Postnasal drip |
| Sneezing | |
| R06.7 | Sneezing |
| Urticaria | |
| L50 | Urticaria |
| L50.0 | Allergic urticaria |
| L50.1 | Idiopathic urticaria |
| L50.2 | Urticaria due to cold and heat |
| L50.3 | Dermatographic urticaria |
| L50.4 | Vibratory urticaria |
| L50.5 | Cholinergic urticaria |
| L50.6 | Contact urticaria |
| L50.8 | Other urticaria |
| L50.9 | Urticaria, unspecified |
| L56.3 | Solar urticaria |
| O26.86 | Pruritic urticarial papules and plaques of pregnancy (PUPPp) |
| Vasomotor rhinitis | |
| J30.0 | Vasomotor rhinitis |
| 0-9 | A-Z |
|---|---|
| H10.1 | Acute atopic conjunctivitis |
| H10.10 | Acute atopic conjunctivitis, unspecified eye |
| H10.11 | Acute atopic conjunctivitis, right eye |
| H10.12 | Acute atopic conjunctivitis, left eye |
| H10.13 | Acute atopic conjunctivitis, bilateral |
| H10.44 | Vernal conjunctivitis |
| H10.45 | Other chronic allergic conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| J30.0 | Vasomotor rhinitis |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J30.5 | Allergic rhinitis due to food |
| J30.8 | Other allergic rhinitis |
| J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
| J30.89 | Other allergic rhinitis |
| J30.9 | Allergic rhinitis, unspecified |
| L29.8 | Other pruritus |
| L29.9 | Pruritus, unspecified |
| L50 | Urticaria |
| L50.0 | Allergic urticaria |
| L50.1 | Idiopathic urticaria |
| L50.2 | Urticaria due to cold and heat |
| L50.3 | Dermatographic urticaria |
| L50.3 | Dermatographic urticaria |
| L50.4 | Vibratory urticaria |
| L50.5 | Cholinergic urticaria |
| L50.6 | Contact urticaria |
| L50.8 | Other urticaria |
| L50.9 | Urticaria, unspecified |
| L56.3 | Solar urticaria |
| O26.86 | Pruritic urticarial papules and plaques of pregnancy (PUPPp) |
| R06.7 | Sneezing |
| R09.81 | Nasal congestion |
| R09.82 | Postnasal drip |
| T78.00xA | Anaphylactic reaction due to unspecified food, initial encounter |
| T78.01xA | Anaphylactic reaction due to peanuts, initial encounter |
| T78.02xA | Anaphylactic reaction due to shellfish (crustaceans), initial encounter |
| T78.03xA | Anaphylactic reaction due to other fish, initial encounter |
| T78.04xA | Anaphylactic reaction due to fruits and vegetables, initial encounter |
| T78.05xA | Anaphylactic reaction due to tree nuts and seeds, initial encounter |
| T78.06xA | Anaphylactic reaction due to food additives, initial encounter |
| T78.07xA | Anaphylactic reaction due to milk and dairy products, initial encounter |
| T78.08xA | Anaphylactic reaction due to eggs, initial encounter |
| T78.09xA | Anaphylactic reaction due to other food products, initial encounter |
| T78.2xxA | Anaphylactic shock, unspecified, initial encounter |
| T80.51 | Anaphylactic reaction due to administration of blood and blood products |
| T80.52xA | Anaphylactic reaction due to vaccination, initial encounter |
| T80.59xA | Anaphylactic reaction due to other serum, initial encounter |
| T88.6xxA | Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, initial encounter |
Formulary Reference Tool